The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s small molecule drug discovery market report forecasts the small molecule drug discovery market size to grow to $82.56 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Small Molecule Drug Discovery Market Report 2023 – https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Small Molecule Drug Discovery Market Size Forecast
The global small molecule drug discovery market is expected to grow from $52.14 billion in 2022 to $57.51 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global small molecule drug discovery market size is expected to reach $82.56 billion in 2027 at a CAGR of 9.5%.

North America held the largest small molecule drug discovery market share, and Europe was the fastest-growing region in 2022.

Key Small Molecule Drug Discovery Market Driver ­– Rise In The Incidence Of Chronic Diseases
According to a report published by the National Institutes of Health (NIH), a biomedical research agency based in the United States, the number of people aged 50 and older with at least one chronic illness in the United States is expected to increase by 99.5% by 2023, from 71.522 million in 2020 to 142.66 million in 2050. Furthermore, the number of people suffering from multimorbidity will increase by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. As a result, the increased prevalence of chronic diseases is propelling the small molecule drug discovery industry forward.

Request for A Sample Of The Global Small Molecule Drug Discovery Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

Key Small Molecule Drug Discovery Market Trend – Technological Advancement
Major players in the small molecule drug discovery industry are concentrating on the development of new products. Dotmatics, a US-based provider of digital science platforms, for example, launched Small Molecule Drug Discovery Solution in January 2023. It is one-of-a-kind in that it includes an integrated scientific R&D platform with pre-configured workflows and increased data management features. It lowers operational inefficiencies and accelerates the transition of data from insights to decisions.

Small Molecule Drug Discovery Market Segment
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process/Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Small Molecule Drug Discovery Market Major Players and Strategies
Major players in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 21st Century Therapeutics Inc., 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Immunocure Inc., and Labcorp Drug Development.

Sierra Oncology Inc. (Sierra Oncology) was acquired by GSK Plc., a UK-based pharmaceutical and biotechnology firm, for 1.9 billion dollars in July 2022. This acquisition expands GSK’s advanced cancer portfolio, demonstrating the company’s commitment to improving patient outcomes while increasing shareholder value. Sierra is also intended to assist GSK in establishing a sustainable process of new treatments through the use of modalities such as small compounds, antibodies, antibody-drug conjugates, and cell therapy. Sierra Oncology Inc. is a clinical-stage drug development firm situated in the United States that develops targeted therapies for cancer patients.

The Small Molecule Drug Discovery Global Market Report 2023 covers regional data on small molecule drug discovery market size, small molecule drug discovery market trends and drivers, opportunities, strategies, and small molecule drug discovery market competitor analysis. The countries covered in the small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The discovery of a medicine with a low molecular weight that may easily infiltrate cells is referred to as small molecule drug discovery. Small-molecule pharmaceuticals are used to treat or prevent disease.

View More Reports Related To The Small Molecule Drug Discovery Market –
Drugs For Immunotherapy Global Market Report 2023
Drug Delivery Devices Global Market Report 2023
Small Arms And Light Weapons Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: